Byrne Asset Management LLC Lexaria Bioscience Corp. Transaction History
Byrne Asset Management LLC
- $112 Million
- Q1 2025
A detailed history of Byrne Asset Management LLC transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Byrne Asset Management LLC holds 28,905 shares of LEXX stock, worth $26,014. This represents 0.04% of its overall portfolio holdings.
Number of Shares
28,905
Previous 13,000
122.35%
Holding current value
$26,014
Previous $27,000
81.48%
% of portfolio
0.04%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
1.28MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA550KShares$494,9520.05% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$155,2110.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6130KShares$117,0220.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA128KShares$115,0830.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL61.3KShares$55,1250.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $5.36M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...